Dietary intervention restores gut microbiome and offers protection against chronic diseases

Findings indicate that a microbiome restoration diet improves gut health and reduces chronic disease markers, highlighting its cardiometabolic benefits.

Ono Pharmaceutical acquires cancer-focused biopharma Deciphera for $2.4bn – Pharmaceutical Technology

Share this article Deciphera also brings ripretinib, marketed under the brand name Qinlock, to the deal. Credits: ESB Professional/Shutterstock.com Deciphera Pharmaceuticals is set to be

April 29, 2024

M&A activity in the pharmaceutical industry in Australia remained flat in 2023

In value terms, M&A activity in Australia decreased by 41% in Q2 2023 compared with the previous quarter’s total of $846.7m and rose by 46%

July 28, 2023

Optimi Health Celebrates Encouraging Results from the MAPS Phase 3 MDMA-Assisted Therapy Clinical Trial – Psychedelic Alpha

VANCOUVER, British Columbia, Sept. 14, 2023 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian psychedelics drug research and formulation

September 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.